Skip to content

BioMarin Pharmaceutical

BioMarin Pharmaceutical

BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions.

Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments

for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2 (a form of Batten disease) and a number of forms of MPS (mucopolysaccharidosis) offer new

possibilities for patients and families who previously had few, if any, available options. More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions.

Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise and our world-class manufacturing capabilities. At the heart of BioMarin

is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world.

Biomarin logo
Contact
Address
Matrix THREE, Science Park 402, 1098 XH Amsterdam
Phone number

BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions.

Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a portfolio of therapies since our founding in 1997. Our revolutionary treatments

for conditions like achondroplasia (the most common form of dwarfism), PKU (phenylketonuria), CLN2 (a form of Batten disease) and a number of forms of MPS (mucopolysaccharidosis) offer new

possibilities for patients and families who previously had few, if any, available options. More recently, with the close of the Amicus acquisition, our portfolio has expanded to include therapies for Fabry disease and Pompe disease, expanding our ability to reach more people living with rare genetic conditions.

Our success comes from our unwavering commitment to excellence, our deep understanding of patient needs, our scientific expertise and our world-class manufacturing capabilities. At the heart of BioMarin

is a dedicated team of the brightest minds in the industry working together to deliver innovative therapies to patients and families around the world.

Contact
Address
Matrix THREE, Science Park 402, 1098 XH Amsterdam